- Home
- FSLY vs OCUL Comparison
FSLY vs OCUL Comparison
Compare FSLY & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSLY | OCUL |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FSLY | OCUL |
|---|---|---|
| Price | $19.90 | $10.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $18.00 | ★ $23.56 |
| AVG Volume (30 Days) | ★ 4.7M | 3.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.19 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $624,018,000.00 | $1,990,000.00 |
| Revenue This Year | $16.39 | $7.93 |
| Revenue Next Year | $10.73 | $96.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.78 | 3.48 |
| 52 Week Low | $6.29 | $6.23 |
| 52 Week High | $34.82 | $16.44 |
Technical Indicators
Market Signals| Indicator | FSLY | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 55.50 |
| Support Level | $15.95 | $9.24 |
| Resistance Level | $20.06 | $12.38 |
| Average True Range (ATR) | 1.31 | 0.50 |
| MACD | 0.37 | -0.02 |
| Stochastic Oscillator | 75.29 | 40.21 |
Price Performance
Historical ComparisonAbout FSLY Fastly Inc.
Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.